MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast

被引:205
作者
Wen, Zhibo [1 ,2 ]
Hu, Shuguang [3 ]
Huang, Fanheng [2 ]
Wang, Xianlong [2 ]
Guo, Linglang [4 ]
Quan, Xianyue [2 ]
Wang, Silun [1 ]
Zhou, Jinyuan [1 ,5 ]
机构
[1] Johns Hopkins Univ, Div MR Res, Dept Radiol, Baltimore, MD 21218 USA
[2] So Med Univ, Zhujiang Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China
[3] Philips Healthcare, Guangzhou, Guangdong, Peoples R China
[4] So Med Univ, Zhujiang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[5] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA
关键词
CEST; APT; Magnetization transfer; Brain tumor; Protein; MRI; SATURATION-TRANSFER CEST; GLIOBLASTOMA-MULTIFORME; PERITUMORAL EDEMA; MALIGNANT GLIOMAS; CEREBRAL GLIOMAS; GLIAL NEOPLASMS; DIFFUSION; SPECTROSCOPY; PERFUSION; AGENTS;
D O I
10.1016/j.neuroimage.2010.02.050
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amide proton transfer (APT) imaging is a novel MRI technique, in which the amide protons of endogenous proteins and peptides are irradiated to accomplish indirect detection using the bulk water signal. In this paper, the APT approach was added to a standard brain MRI protocol at 3 T. and twelve patients with high-grade gliomas confirmed by histopathology were scanned. It is shown that all tumors, including one with minor gadolinium enhancement, showed heterogeneous hyperintensity on the APT images. The average APT signal intensities of the viable tumor cores were significantly higher than those of peritumoral edema and normal-appearing white matter (P 0.001). The average APT signal intensities were significantly lower in the necrotic regions than in the viable tumor cores (P=0.004). The APT signal intensities of the cystic cavities were similar to those of the viable tumor cores (P>0.2). The initial results show that APT imaging at the protein and peptide level may enhance non-invasive identification of tissue heterogeneity in high-grade brain tumors. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:616 / 622
页数:7
相关论文
共 35 条
[1]   Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications [J].
Aime, S ;
Barge, A ;
Delli Castelli, D ;
Fedeli, F ;
Mortillaro, A ;
Nielsen, FU ;
Terreno, E .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (04) :639-648
[2]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[3]   Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: A summary of the medical literature reporting [J].
Broome, Dale R. .
EUROPEAN JOURNAL OF RADIOLOGY, 2008, 66 (02) :230-234
[4]  
BURGER PC, 1983, J NEUROSURG, V58, P159, DOI 10.3171/jns.1983.58.2.0159
[5]   Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas [J].
Catalaa, Isabelle ;
Henry, Roland ;
Dillon, William P. ;
Graves, Edward E. ;
McKnight, Tracy R. ;
Lu, Ying ;
Vigneron, Daniel B. ;
Nelson, Sarah J. .
NMR IN BIOMEDICINE, 2006, 19 (04) :463-475
[6]  
Cha Soonmee, 2004, Top Magn Reson Imaging, V15, P279, DOI 10.1097/00002142-200410000-00002
[7]   Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma [J].
Chang, Susan M. ;
Nelson, Sarah ;
Vandenberg, Scott ;
Cha, Soonmee ;
Prados, Michael ;
Butowski, Nicholas ;
McDermott, Michael ;
Parsa, Andrew T. ;
Aghi, Manish ;
Clarke, Jennifer ;
Berger, Mitchel .
JOURNAL OF NEURO-ONCOLOGY, 2009, 92 (03) :401-415
[8]   Dynamic magnetic resonance perfusion imaging of brain tumors [J].
Covarrubias, DJ ;
Rosen, BR ;
Lev, MH .
ONCOLOGIST, 2004, 9 (05) :528-537
[9]  
Field Aaron S, 2004, Top Magn Reson Imaging, V15, P315, DOI 10.1097/00002142-200410000-00004
[10]   Quantification of tumour response to radiotherapy [J].
Gong, QY ;
Eldridge, PR ;
Brodbelt, AR ;
García-Fiñana, M ;
Zaman, A ;
Jones, B ;
Roberts, N .
BRITISH JOURNAL OF RADIOLOGY, 2004, 77 (917) :405-413